Legal Opinion
HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.
District Court, N.D. California
Decided November 2, 2022No. 3:22-cv-04109Unknown
1Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 HOTSPOT THERAPEUTICS, INC., Case No. 22-cv-04109-TSH 8 Plaintiff, ORDER RE: COUNTERCLAIM DEFENDANTS’ MOTIONS TO 9 v. DISMISS AND RELATED ADMINISTRATIVE MOTIONS TO 10 NURIX THERAPEUTICS, INC., SEAL 11 Defendant. Re: Dkt. Nos. 24, 25, 28, 29, 36, 37, 38, 39, 12 40, 41, 42, 43 13 14 I. INTRODUCTION 15 Pending before the Court are Plaintiff/Counterclaim Defendant HotSpot Therapeautics, 16 Inc’s (“HotSpot”) Motion to Dismiss Defendant Nurix Therapeutics, Inc.’s (“Nurix”) 17 Counterclaims (ECF No. 25), Counterclaim Defendant…
2Cases cited30 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Lopez v. SmithCourt of Appeals for the Ninth Circuit · 2000
- Walden v. FioreSupreme Court of the United States · 2014
- Center for Auto Safety v. Chrysler Group, LLCCourt of Appeals for the Ninth Circuit · 2016
25 more not listed; retrieve them via the Exa API.